Cidara Therapeutics
CDTX
CDTX
55 hedge funds and large institutions have $40.5M invested in Cidara Therapeutics in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
55% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 22
Holders
55
Holding in Top 10
2
Calls
$155K
Puts
$62K
Top Buyers
| 1 | +$2.45M | |
| 2 | +$1.23M | |
| 3 | +$1.04M | |
| 4 |
Renaissance Technologies
New York
|
+$480K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$353K |
Top Sellers
| 1 | -$2.95M | |
| 2 | -$1.18M | |
| 3 | -$982K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$609K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$526K |